about
Combining qualitative and quantitative imaging evaluation for the assessment of genomic DNA integrity: The SPIDIA experienceNqA: an R-based algorithm for the normalization and analysis of microRNA quantitative real-time polymerase chain reaction data.Data and performances evaluation of the SPIDIA-DNA Pan-European External Quality Assessment: 2nd SPIDIA-DNA laboratory report.The focus on sample quality: Influence of colon tissue collection on reliability of qPCR data.FCI: an R-based algorithm for evaluating uncertainty of absolute real-time PCR quantificationGenomic profiling by whole-genome single nucleotide polymorphism arrays in Wilms tumor and association with relapse.Effects of warm ischemic time on gene expression profiling in colorectal cancer tissues and normal mucosaEvaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases.Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer.Biomarkers for monitoring pre-analytical quality variation of mRNA in blood samples.SPIDIA-RNA: second external quality assessment for the pre-analytical phase of blood samples used for RNA based analysesFANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factorExternal Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scaleAssociation between CASP8 -652 6N del polymorphism (rs3834129) and colorectal cancer risk: results from a multi-centric studyA methodological procedure for evaluating the impact of hemolysis on circulating microRNAs.Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancerIdentification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation.Comment on 'Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'-Methodological challenges in combining miRNAs as circulating biomarkersReceptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma.Developing miRNA signatures: a multivariate prospective.SPIDIA-RNA: first external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses.Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall.External quality assessment schemes for real-time PCR: a statistical procedure to corrective actions.SPIDIA-DNA: an External Quality Assessment for the pre-analytical phase of blood samples used for DNA-based analyses.Reproducibility in the diagnosis of needle core biopsies of non-palpable breast lesions: an international study using virtual slides published on the world-wide web.Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial.Second SPIDIA-DNA External Quality Assessment (EQA): Influence of pre-analytical phase of blood samples on genomic DNA quality.X chromosome inactivation pattern in BRCA gene mutation carriers.The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers.A BRCA1 promoter variant (rs11655505) and breast cancer risk.A normalization strategy for the analysis of plasma microRNA qPCR data in colorectal cancer.Breast pathology guideline implementation in low- and middle-income countries.Effects of Transport and Storage Conditions on Gene Expression in Blood Samples.EQUAL-quant: an international external quality assessment scheme for real-time PCR.SNPs in ultraconserved elements and familial breast cancer risk.Influence of pre-analytical procedures on genomic DNA integrity in blood samples: the SPIDIA experience.Circulating free DNA in a screening program for early colorectal cancer detection.Implementation of a proficiency testing for the assessment of the preanalytical phase of blood samples used for RNA based analysis.High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial
P50
Q28364903-49A1FE4D-3800-4CA1-8682-8BC7EA587E96Q30828643-C373064F-18BC-4776-B204-E6DF582FB570Q31053898-4DB7A446-C8DF-492A-AA36-5B576D4FC8AFQ31112809-84812F39-F433-43FE-9EA6-23FB8DBA80A0Q33314153-E4961021-6853-4195-BD45-27B3854F6167Q34190897-7CB21A6C-E903-4711-BB9D-67A168965CF7Q34545033-EAC49334-C62D-49B1-8F31-C2FC6108AC45Q35009015-E71A06BB-3D6D-42AA-86D7-3BE4C456D919Q35059203-FD983D64-969C-4353-A888-6477083677C6Q35392901-9C1C1152-34E0-42D3-93A9-BEC64BDEFCB7Q35407523-C69F35F0-7D1D-4528-BE2B-343F04D2167EQ35999309-CEE7612B-E429-49FD-8EC8-EA2085DAFABBQ37153505-1891BD7D-9E45-4E3D-A624-CBA3994151DFQ37499529-BB561575-CA04-418E-93E6-454397492225Q37593931-C8C5165B-CF0A-40D0-9139-CC173D7D9EFCQ37594418-BC6DD705-FA39-4AFF-8BF2-F5663A237666Q39321320-FBF530B4-609A-43AB-B632-9391275E8B01Q39394993-CA80301A-5A21-4193-98BB-75A29CC39665Q41512938-200AA0C6-9CF1-4F66-ABF0-5D714B17905FQ41605972-CD0B8B1E-4982-4C77-B4E0-C5D52149E4AAQ42434363-5C335CAF-0BEC-43A7-A28A-7DA76C29A864Q43485831-5F4447B2-DD78-452A-A40A-4B6C71FE1745Q44382222-1CE55F07-D108-48FC-BDEC-6229515D345DQ45749384-D0203CEC-EF51-450A-B9DC-2ADA299A4D8AQ45928240-9A0B5C46-AA96-4FF8-9E9D-034BA094A806Q48555799-8DCD8CB6-A6CC-4CB7-89E2-3A5CCCB0F064Q48840392-1E8BF23A-3975-44CB-9F3F-D52C3F7EE0C6Q50745119-B6F2E19D-38A7-4595-9574-B8BCA1E34D4CQ51296900-1DB9947D-8CFC-45B2-B77A-0628217E50AEQ51551407-BFA6812C-94E0-4E22-80D9-D3CBB28FC34BQ51569689-02E2682C-7EE8-4F89-B3F6-5032BCA4FAFFQ51775702-D809D844-1285-4A26-B79F-FA2FF8395263Q53059008-299E33A8-BB41-4C29-B148-B1C48211FBEEQ53174611-1B1EA3D8-6776-4B94-B87C-8256EDEFE204Q53254706-944AB398-1AF7-4627-9996-300D9976C312Q53314159-8E261397-8D6A-49D3-A6CA-0177EA45D6BDQ54181342-4E76DD47-6A77-4737-ADA8-B87BE4D0709FQ54207521-C644C7A8-517F-4B05-9634-55D8085F444FQ54326924-EA6E494F-5F77-409B-B7FC-095C89188AA0Q56390090-FAAF608A-3182-4379-8EB7-B609FBD3CD3E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sara Pizzamiglio
@ast
Sara Pizzamiglio
@en
Sara Pizzamiglio
@es
Sara Pizzamiglio
@nl
Sara Pizzamiglio
@sl
type
label
Sara Pizzamiglio
@ast
Sara Pizzamiglio
@en
Sara Pizzamiglio
@es
Sara Pizzamiglio
@nl
Sara Pizzamiglio
@sl
prefLabel
Sara Pizzamiglio
@ast
Sara Pizzamiglio
@en
Sara Pizzamiglio
@es
Sara Pizzamiglio
@nl
Sara Pizzamiglio
@sl
P1053
C-1061-2017
P106
P1153
23568391600
P21
P31
P3829
P496
0000-0002-7759-0550